Vera Regitz-Zagrosek
Public Health, Environmental and Occupational Health · 2010–2021
A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Public Health, Environmental and Occupational Health — 47 citations into it
- Genetics — 20 citations into it
Whom Vera Regitz-Zagrosek trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Vera Regitz-Zagrosek's perspective
Ordered by how strongly the researchers Vera Regitz-Zagrosek trusts endorse each paper. Same corpus, a different order for every researcher.
- Clinical Features, Management, and Prognosis of Spontaneous Coronary Artery Dissection (Circulation)
- The organizational-activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues (Hormones and Behavior)
- MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts (Nature)
- A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure (Proceedings of the National Academy of Sciences of the United States of America)
- MicroRNAs Play an Essential Role in the Development of Cardiac Hypertrophy (Circulation Research)
- Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. (Cell)
- Rapamycin fed late in life extends lifespan in genetically heterogeneous mice (Nature)
- Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. (European Heart Journal)
- A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
- Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. (New England Journal of Medicine)
Their papers
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. (2021) — 5,029 citations
- 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. (2018) — 1,810 citations
- Mechanistic Pathways of Sex Differences in Cardiovascular Disease. (2017) — 648 citations
- Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. (2016) — 652 citations
- ESC Guidelines on the Management of Cardiovascular Diseases During Pregnancy (2012) — 757 citations
- Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy (2010) — 993 citations